69 related articles for article (PubMed ID: 7794962)
1. Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranes.
Morré DJ; Wilkinson FE; Lawrence J; Cho N; Paulik M
Biochim Biophys Acta; 1995 Jun; 1236(2):237-43. PubMed ID: 7794962
[TBL] [Abstract][Full Text] [Related]
2. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
[TBL] [Abstract][Full Text] [Related]
3. HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity.
Morré DJ; Morré DM; Stevenson J; MacKellar W; McClure D
Biochim Biophys Acta; 1995 May; 1244(1):133-40. PubMed ID: 7766649
[TBL] [Abstract][Full Text] [Related]
4. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
Morré DJ
Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
[TBL] [Abstract][Full Text] [Related]
5. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
[TBL] [Abstract][Full Text] [Related]
6. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1998 Mar; 1369(2):185-92. PubMed ID: 9518604
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1997 Feb; 1355(2):114-20. PubMed ID: 9042331
[TBL] [Abstract][Full Text] [Related]
8. A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984).
Morré DJ; Jacobs E; Sweeting M; de Cabo R; Morré DM
Biochim Biophys Acta; 1997 Apr; 1325(1):117-25. PubMed ID: 9106489
[TBL] [Abstract][Full Text] [Related]
9. Proton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N'-(4-cholorophenyl) urea (LY181984).
Sun E; Lawrence J; Morré DM; Sun I; Crane FL; MacKellar WC; Morré DJ
Biochem Pharmacol; 1995 Oct; 50(9):1461-8. PubMed ID: 7503797
[TBL] [Abstract][Full Text] [Related]
10. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity.
Morré DJ; Chueh PJ; Lawler J; Morré DM
J Bioenerg Biomembr; 1998 Oct; 30(5):477-87. PubMed ID: 9932650
[TBL] [Abstract][Full Text] [Related]
11. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
[TBL] [Abstract][Full Text] [Related]
12. Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients.
Kim C; MacKellar WC; Cho NM; Byrn SR; Morré DJ
Biochim Biophys Acta; 1997 Mar; 1324(2):171-81. PubMed ID: 9092704
[TBL] [Abstract][Full Text] [Related]
13. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients.
Morré DJ; Reust T
J Bioenerg Biomembr; 1997 Jun; 29(3):281-9. PubMed ID: 9298713
[TBL] [Abstract][Full Text] [Related]
14. A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells.
del Castillo-Olivares A; Yantiri F; Chueh PJ; Wang S; Sweeting M; Sedlak D; Morré DM; Burgess J; Morré DJ
Arch Biochem Biophys; 1998 Oct; 358(1):125-40. PubMed ID: 9750173
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
Houghton PJ; Sosinski J; Thakar JH; Boder GB; Grindey GB
Biochem Pharmacol; 1995 Mar; 49(5):661-8. PubMed ID: 7887981
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.
Neubauer BL; Merriman RL; Best KL; Goode RL; Sarosdy MF; Tanzer LR; Howbert JJ
J Urol; 1992 Feb; 147(2):500-4. PubMed ID: 1732631
[TBL] [Abstract][Full Text] [Related]
17. Characterization and significance of sulfonylurea receptors.
Siconolfi-Baez L; Banerji MA; Lebovitz HE
Diabetes Care; 1990 Aug; 13 Suppl 3():2-8. PubMed ID: 2209340
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial sulfonylurea receptor: identification and characterization.
Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
[TBL] [Abstract][Full Text] [Related]
19. Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
Marie J; Roy C
Mol Pharmacol; 1988 Apr; 33(4):432-40. PubMed ID: 2965789
[TBL] [Abstract][Full Text] [Related]
20. Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells.
Wilkinson F; Kim C; Cho N; Chueh PJ; Leslie S; Moya-Camarena S; Wu LY; Morré DM; Morré DJ
Arch Biochem Biophys; 1996 Dec; 336(2):275-82. PubMed ID: 8954575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
